For: | Lei Y, Sheng JH, Jin XR, Liu XB, Zheng XY, Xu XH. Study on the efficacy of early treatment with pirfenidone on the lung function of patients with idiopathic pulmonary fibrosis. World J Clin Cases 2024; 12(22): 4913-4923 [PMID: 39109030 DOI: 10.12998/wjcc.v12.i22.4913] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v12/i22/4913.htm |
Number | Citing Articles |
1 |
Basma M E Mohamed, Mohamed E A Abdelrahim. Timing impact on the initiation of pirfenidone therapy on idiopathic pulmonary fibrosis disease progression. World Journal of Clinical Cases 2024; 12(32): 6538-6542 doi: 10.12998/wjcc.v12.i32.6538
|
2 |
Jin-Wei Zhang. Early pirfenidone treatment enhances lung function in idiopathic pulmonary fibrosis patients. World Journal of Clinical Cases 2024; 12(28): 6247-6249 doi: 10.12998/wjcc.v12.i28.6247
|
3 |
Li-Ying Xu, Yi Yu, Lu-Sha Cen. Insight into the efficacy and safety of pirfenidone: The treatment of idiopathic pulmonary fibrosis. World Journal of Clinical Cases 2025; 13(14): 98769 doi: 10.12998/wjcc.v13.i14.98769
|